ClinicalThought

Share

Program Content

Activities

  • Oral SERD Therapy
    Ensuring Optimal Clinical Benefit From Oral SERD Therapy in Patients With HR+/HER2- Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 01, 2024

    Expires: February 28, 2025

Faculty

cover img faculity

Julia A LaBarbera, MSN, RN, AGACNP-BC

Nurse Practitioner
UCLA Hematology Oncology
Santa Monica, California

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner